J Physiol 577:5919, PMID: 17008380 Lehre KP, Levy LM, Ottersen OP, Storm-Mathisen J, Danbolt NC (1995) Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations
Evidence quality favors IV for acute toxin exposure
PubMed indexes the broader GHK-Cu topical serum research across subsequent replication studies
Key Safety Differentiators No IGF-1 elevation: AOD-9604 does not stimulate IGF-1, meaning it avoids risks such as organ/tissue overgrowth or acromegaly No glucose disruption: Clinical data shows it does not impair insulin sensitivity or worsen blood sugar regulation Comparable to placebo: In obesity trials, the incidence of adverse effects was similar to placebo groups, underscoring its tolerability Legal Status of AOD-9604 United States: AOD-9604 is not FDA-approved as a drug, dietary supplement, or weight loss therapy
The cellular microbiology of Salmonellae interactions with macrophages
The most common cause of degenerative labral tears is a condition known as femoroacetabular impingement (FAI)
